A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes

por Stephen A. Harrison, Nadege Gunn, Guy W. Neff, Anita Kohli, Liping Liu, Abbey Flyer, Lawrence Goldkind, Adrian M. Di Bisceglie
Publicado 2021

LIVRQNac (AXA1125) ENHANCES INSULIN SENSITIVITY IN PRIMARY HUMAN HEPATOCYTES AND IN SUBJECTS WITH NAFLD AND T2D

por Seth J. Baum, Stephen A. Harrison, Nadege T. Gunn, Ziad H. Younes, Anita Kohli, Rashmee Patil, Juan P. Fras, Michael Hamill, Nadine Daou, Jeff Zhao, Manu V. Chakravarthy, Margaret J. Koziel
Publicado 2021